Patents by Inventor Stany Depraetere

Stany Depraetere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR
    Publication number: 20110129489
    Abstract: The present invention relates to the generation of an immune response against a target antigen using a DNA and viral vector in a specific administration pattern.
    Type: Application
    Filed: July 7, 2008
    Publication date: June 2, 2011
    Inventors: Erik Depla, Annegret Van Der Aa, Sofie De Schepper, Stany Depraetere, Karen De Vreese
  • HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGES
    Publication number: 20080274144
    Abstract: The invention relates to recombinantly or synthetically produced HCV E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues. The invention further relates to viral-like particles and compositions comprising said HCV E1 envelope proteins or parts thereof as well as to methods using said HCV E1 envelope proteins or parts thereof, and to kits comprising said HCV E1 envelope proteins or parts thereof.
    Type: Application
    Filed: March 24, 2008
    Publication date: November 6, 2008
    Applicant: INNOGENETICS N.V
    Inventors: Stany Depraetere, Erik Depla, Gert Verheyden, Alfons Bosman
  • HCV E1 comprising specific disulfide bridges
    Patent number: 7413741
    Abstract: The invention relates to recombinantly or synthetically produced HCV E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues. The invention further relates to viral-like particles and compositions comprising said HCV E1 envelope proteins or parts thereof as well as to methods using said HCV E1 envelope proteins or parts thereof, and to kits comprising said HCV E1 envelope proteins or parts thereof.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: August 19, 2008
    Assignee: Innogenetics N.V.
    Inventors: Stany Depraetere, Erik Depla, Gert Verheyden, Alfons Bosman
  • Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
    Publication number: 20070031377
    Abstract: The present invention relates to preventing, or treating and/or reducing the severity or progression of Type 1 immune response-mediated inflammatory lung disease. More particularly, the present invention provides a method for preventing or treating chronic obstructive pulmonary disease (COPD), severe asthma, sarcoidosis, berylliosis or cystic fibrosis by neutralizing or reducing IFN? bioactivity which can be achieved either by in vivo administration of IFN? neutralizing molecules or by in vivo immunization with pharmaceutical compositions comprising immunogenic IFN? proteins or IFN?-derived (poly)peptides or their corresponding nucleic acid sequences.
    Type: Application
    Filed: March 26, 2004
    Publication date: February 8, 2007
    Inventors: Stany Depraetere, Katrien Lorre, Marie-Ange Buyse
  • HCV E1 comprising specific disulfide bridges
    Publication number: 20060034861
    Abstract: The invention relates to recombinantly or synthetically produced HCV E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues. The invention further relates to viral-like particles and compositions comprising said HCV E1 envelope proteins or parts thereof as well as to methods using said HCV E1 envelope proteins or parts thereof, and to kits comprising said HCV E1 envelope proteins or parts thereof.
    Type: Application
    Filed: March 8, 2005
    Publication date: February 16, 2006
    Applicant: INNOGENETICS N.V
    Inventors: Stany Depraetere, Erik Depla, Gert Verheyden, Alfons Bosman